Gene · 501
Papers3,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Review on the Pharmacological Properties of Phillyrin. | Molecules | 2022 | 35744798 | PubTator, text mining | PubMed |
| Long-term course of early onset developmental and epileptic encephalopathy associated with 2q24.3 microduplication. | Epilepsy Behav Rep | 2022 | 35733834 | PubTator, text mining | PubMed |
| Metabolic cycles and signals for insulin secretion. | Cell Metab | 2022 | 35728586 | PubTator, text mining | PubMed |
| α-Synuclein Impacts on Intrinsic Neuronal Network Activity Through Reduced Levels of Cyclic AMP and Diminished Numbers of Active Presynaptic Terminals. | Front Mol Neurosci | 2022 | 35721317 | PubTator, text mining | PubMed |
| Analysis of clinical phenotypic and genotypic spectra in 36 children patients with Epilepsy of Infancy with Migrating Focal Seizures. | Sci Rep | 2022 | 35715422 | PubTator, text mining | PubMed |
| Exploring the Activity Profile of TbrPDEB1 and hPDE4 Inhibitors Using Free Energy Perturbation. | ACS Med Chem Lett | 2022 | 35707144 | PubTator, text mining | PubMed |
| Exploring the Structural and Functional Effects of Nonsynonymous SNPs in the Human Serotonin Transporter Gene Through In Silico Approaches. | Bioinform Biol Insights | 2022 | 35706533 | PubTator, text mining | PubMed |
| Development of PD3 and PD3-B for PDEδ inhibition to modulate KRAS activity. | J Enzyme Inhib Med Chem | 2022 | 35695156 | PubTator, text mining | PubMed |
| Advances in the Study of Inhaled Formulations for the Treatment of Pulmonary Arterial Hypertension. | Appl Bionics Biomech | 2022 | 35694279 | PubTator, text mining | PubMed |
| The Different Effects of Direct Bilirubin on Portopulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension. | Int J Clin Pract | 2022 | 35685569 | PubTator, text mining | PubMed |
| An Integrated Multi-Omic Network Analysis Identifies Seizure-Associated Dysregulated Pathways in the GAERS Model of Absence Epilepsy. | Int J Mol Sci | 2022 | 35682742 | PubTator, text mining | PubMed |
| PBRM1 deficiency oncogenic addiction is associated with activated AKT-mTOR signalling and aerobic glycolysis in clear cell renal cell carcinoma cells. | J Cell Mol Med | 2022 | 35672925 | PubTator, text mining | PubMed |
| Ongoing Clinical Trials in Aging-Related Tissue Fibrosis and New Findings Related to AhR Pathways. | Aging Dis | 2022 | 35656117 | PubTator, text mining | PubMed |
| Recent insights into the management of treatment-resistant pediatric atopic dermatitis. | Int J Womens Dermatol | 2022 | 35647254 | PubTator, text mining | PubMed |
| The Clinical Features and Long-Term Follow-Up of Vitamin B6-Responsive Infantile Spasms in a Chinese Cohort. | Front Neurol | 2022 | 35645976 | PubTator, text mining | PubMed |
| High-throughput drug screening allowed identification of entry inhibitors specifically targeting different routes of SARS-CoV-2 Delta and Omicron/BA.1. | Biomed Pharmacother | 2022 | 35643072 | PubTator, text mining | PubMed |
| Phosphorus MRS of healthy human spleen. | NMR Biomed | 2022 | 35642280 | PubTator, text mining | PubMed |
| Drug repurposing for the treatment of COVID-19. | J Pharmacol Sci | 2022 | 35641023 | PubTator, text mining | PubMed |
Partial Differential Equation-Constrained Diffeomorphic Registration from Sum of Squared Differences to Normalized Cross-Correlation, Normalized Gradient Fields, and Mutual Information: A Unifying Framework. | Sensors (Basel) | 2022 | 35632143 | PubTator, text mining | PubMed |
Individually Tailored Remote Physiotherapy Program Improves Participation and Autonomy in Activities of Everyday Life along with Exercise Capacity, Self-Efficacy, and Low-Moderate Physical Activity in Patients with Pulmonary Arterial Hypertension: A Randomized Controlled Study. | Medicina (Kaunas) | 2022 | 35630079 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/501/papers?page=43